5 Questions with Sayeh Nikpay: The 340B Drug Pricing Program | Cornerstone Research

A periodic feature by Cornerstone Research, in which our affiliated experts, senior advisors, and professionals, talk about their research and findings. We interview...

Related Keywords

Health Services ,Minnesota ,United States ,South Carolina ,Maine ,University Of Minnesota ,American ,Melindab Buntin ,Sayeh Nikpay ,Adamj Fein ,Renam Conti ,Claire Mcglave ,School Of Public Health ,Services Administration ,Health Affairs Scholar ,B Program ,B Program Offer ,Cornerstone Research ,Genesis Health Care Inc ,Sanofi Aventis ,Health Services Research ,Us Government Accountability Office ,B Drug Pricing Program Contract Growth ,B Health ,Us District Court ,Health Resources ,Health Centers Fqhcs ,Health Forum ,Third Circuit Court ,B Drug Pricing Program ,Professor Sayeh Nikpay ,Public Health ,Drug Pricing Program ,Disproportionate Share Hospitals ,Federally Qualified Health Centers ,Affordable Care Act ,Third Circuit ,Further Reading ,Between Initiation ,Hospital Safety Net Engagement ,Services Research ,Medicaid Windfall ,Medicaid Expansions ,Target Efficiency ,Hospital Safety Net Subsidies ,Public Economics ,Contract Pharmacy Growth ,County Level Characteristics ,Managed Care ,Drug Pricing Program Contract Growth ,Retail Pharmacies ,Pharmacy Ownership ,Affairs Scholar ,Government Accountability Office ,Manufacturer Discounts ,Program Offer Benefits ,Federal Oversight Needs Improvement ,Program Reached ,Health Care Inc ,Should Consider Legal ,Operational Burdens Imposed ,